Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C

BACKGROUND/AIMS: Peginterferon plus ribavirin remains a standard therapy for patients with chronic hepatitis C (CHC) in Korea. We investigated the efficacy and long-term outcome of peginterferon and ribavirin therapy in Korean patients with CHC, particularly in relation to the stage of liver fibrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Chang Ho, Um, Soon Ho, Kim, Tae Hyung, Yim, Sun Young, Suh, Sang Jun, Yim, Hyung Joon, Seo, Yeon Seok, Choi, Hyuk Soon, Chun, Hoon Jai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003206/
https://www.ncbi.nlm.nih.gov/pubmed/27114417
http://dx.doi.org/10.5009/gnl15360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003206/
https://www.ncbi.nlm.nih.gov/pubmed/27114417
http://dx.doi.org/10.5009/gnl15360

Ejemplares similares